Short-rib thoracic dysplasia 14 with polydactyly

disease
On this page

Also known as SRTD14

Summary

Short-rib thoracic dysplasia 14 with polydactyly (MONDO:0014688) is a disease caused by KIAA0586 (GenCC Strong), with 2 cohort genes.

At a glance

  • Causal gene: KIAA0586 (GenCC Strong)
  • Cohort genes: 2
  • ClinVar variants: 1,319

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameshort-rib thoracic dysplasia 14 with polydactyly
Mondo IDMONDO:0014688
OMIM616546
DOIDDOID:0110096
UMLSC4225286
MedGen901479
GARD0018467
Is cancer (heuristic)no

Also known as: short-rib thoracic dysplasia 14 with polydactyly · SRTD14

Data availability: 1,319 ClinVar variants · 4 GenCC gene-disease records.

Disease family

Classification path: human disease › disease by etiologic mechanism › disease of genetic or genomic mechanism › hereditary disease › autosomal genetic disease › autosomal recessive diseaseautosomal recessive cerebellar ataxia › autosomal recessive congenital cerebellar ataxia › Joubert syndrome and related disordersJoubert syndrome with Jeune asphyxiating thoracic dystrophyshort-rib thoracic dysplasia 14 with polydactyly

Related subtypes (1): Joubert syndrome 21

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

ClinVar germline variants

600 retrieved; paginated sample, class counts are floors:

356 uncertain significance, 171 likely benign, 27 pathogenic, 19 benign, 11 conflicting classifications of pathogenicity, 8 likely pathogenic, 4 benign/likely benign, 3 pathogenic/likely pathogenic, 1 not provided

ClinVarVariant (HGVS)GeneClassificationReview
1458692NC_000014.8:g.(?58711639)(59014694_?)delARID4APathogeniccriteria provided, single submitter
1068589NM_001329943.3(KIAA0586):c.1466_1476del (p.Lys489fs)KIAA0586Pathogeniccriteria provided, single submitter
1070138NM_001329943.3(KIAA0586):c.1935del (p.Val646fs)KIAA0586Pathogeniccriteria provided, single submitter
1070838NM_001329943.3(KIAA0586):c.4495+3755delKIAA0586Pathogeniccriteria provided, single submitter
1072185NM_001329943.3(KIAA0586):c.1667dup (p.Arg557fs)KIAA0586Pathogeniccriteria provided, single submitter
1073545NM_001329943.3(KIAA0586):c.1075_1076del (p.Lys359fs)KIAA0586Pathogeniccriteria provided, single submitter
1175094NM_001329943.3(KIAA0586):c.2536del (p.Val846fs)KIAA0586Pathogeniccriteria provided, single submitter
1175854NM_001329943.3(KIAA0586):c.38del (p.Lys13fs)KIAA0586Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
1350774NM_001329943.3(KIAA0586):c.25G>T (p.Glu9Ter)KIAA0586Pathogeniccriteria provided, single submitter
1357141NM_001329943.3(KIAA0586):c.4456C>T (p.Gln1486Ter)KIAA0586Pathogeniccriteria provided, single submitter
1359882NM_001329943.3(KIAA0586):c.622dup (p.Thr208fs)KIAA0586Pathogeniccriteria provided, single submitter
1369714NM_001329943.3(KIAA0586):c.3353del (p.Pro1118fs)KIAA0586Pathogeniccriteria provided, single submitter
1379251NM_001329943.3(KIAA0586):c.126T>A (p.Cys42Ter)KIAA0586Pathogeniccriteria provided, single submitter
1406363NM_001329943.3(KIAA0586):c.2050C>T (p.Arg684Ter)KIAA0586Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
1429932NM_001329943.3(KIAA0586):c.3700del (p.Val1234fs)KIAA0586Pathogeniccriteria provided, single submitter
1435532NM_001329943.3(KIAA0586):c.1872del (p.Glu625fs)KIAA0586Pathogeniccriteria provided, single submitter
1435732NM_001329943.3(KIAA0586):c.411-1371G>AKIAA0586Pathogeniccriteria provided, single submitter
1452576NM_001329943.3(KIAA0586):c.3638del (p.Pro1213fs)KIAA0586Pathogeniccriteria provided, single submitter
1453326NM_001329943.3(KIAA0586):c.938del (p.Tyr313fs)KIAA0586Pathogeniccriteria provided, single submitter
1453478NM_001329943.3(KIAA0586):c.4495+3777delKIAA0586Pathogeniccriteria provided, single submitter
1453784NM_001329943.3(KIAA0586):c.4225del (p.Glu1409fs)KIAA0586Pathogeniccriteria provided, single submitter
1453816NM_001329943.3(KIAA0586):c.4495+3785A>TKIAA0586Pathogeniccriteria provided, single submitter
1456969NM_001329943.3(KIAA0586):c.3580C>T (p.Gln1194Ter)KIAA0586Pathogeniccriteria provided, multiple submitters, no conflicts
1457512NM_001329943.3(KIAA0586):c.4495+3767A>TKIAA0586Pathogeniccriteria provided, single submitter
1457530NM_001329943.3(KIAA0586):c.2047_2048del (p.Glu683fs)KIAA0586Pathogeniccriteria provided, single submitter
1457538NM_001329943.3(KIAA0586):c.1093del (p.Glu365fs)KIAA0586Pathogeniccriteria provided, single submitter
1517797NM_001329943.3(KIAA0586):c.3142_3144+5delKIAA0586Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
1683813NM_001329943.3(KIAA0586):c.3097dup (p.Ala1033fs)KIAA0586Pathogeniccriteria provided, multiple submitters, no conflicts
1899465NM_001329943.3(KIAA0586):c.653_663del (p.Asp218fs)KIAA0586Pathogeniccriteria provided, single submitter
1938645NM_001329943.3(KIAA0586):c.3718_3719del (p.Leu1240fs)KIAA0586Pathogeniccriteria provided, single submitter

Genes & proteins

Mendelian disease overlap and somatic drivers

GenCC: 10 · Orphanet: 2 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0

GenCC gene–disease validity (cohort genes)

the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.

GeneClassificationInheritanceDiseaseRecords
KIAA0586StrongAutosomal recessiveshort-rib thoracic dysplasia 14 with polydactyly10

Orphanet rare-disease linkage (cohort genes)

GeneOrphanet IDRare disease
KIAA0586Orphanet:397715Joubert syndrome with Jeune asphyxiating thoracic dystrophy
KIAA0586Orphanet:475Isolated Joubert syndrome

Cohort genes → proteins

2 cohort genes, 2 distinct canonical proteins.

Evidence partition

SubsetGenes
multi_evidence2

Cohort genes (full)

SymbolHGNCEnsemblUniProtNameEvidence
KIAA0586HGNC:19960ENSG00000100578Q9BVV6Protein TALPID3gencc,clinvar
ARID4AHGNC:9885ENSG00000032219P29374AT-rich interactive domain-containing protein 4Aclinvar

Cohort function summary

Lead sentence per gene, UniProt-curated.

SymbolProtein nameFunction (lead sentence)
KIAA0586Protein TALPID3Required for ciliogenesis and sonic hedgehog/SHH signaling.
ARID4AAT-rich interactive domain-containing protein 4ADNA-binding protein which modulates activity of several transcription factors including RB1 (retinoblastoma-associated protein) and AR (androgen receptor).

Protein-family classification

Druggable: 0 · Difficult: 0 · Unknown: 2 · Druggable fraction: 0.0

Family distribution

Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.

FamilyGenesFoldFDR
Other/Unknown21.8×0.312

Per-gene assignment

SymbolFamilyDruggable?ECInterPro (top 3)
KIAA0586Other/UnknownnoTALPID3
ARID4AOther/UnknownnoChromo/chromo_shadow_dom, ARID_dom, Tudor

Expression context

Cohort genes with no expression data: 0.

2 cohort genes are a single-cell marker in ≥1 SCXA experiment.

Breadth distribution (Bgee present_calls)

BucketGenes
narrow (1-5 tissues)0
moderate (6-20)0
broad (>20)2
unknown0

Top tissues across cohort

TissueCohort genes
left testis1
male germ line stem cell (sensu Vertebrata) in testis1
right testis1
buccal mucosa cell1
calcaneal tendon1
sural nerve1

Per-gene tissue summary (top 30)

SymbolBgee breadthFANTOM5 breadthSCXATop tissues
KIAA0586247ubiquitousmarkermale germ line stem cell (sensu Vertebrata) in testis, right testis, left testis
ARID4A277ubiquitousmarkercalcaneal tendon, sural nerve, buccal mucosa cell

Protein interactions among cohort

Intra-cohort edges: 0.

Hub genes (top 10 by interactor count)

SymbolInteractor count
ARID4A3,311
KIAA05861,405

Structural data

PDB: 1 · AlphaFold-only: 1 · No structure: 0

Cohort genes with PDB structures (top 30)

SymbolUniProtPDB entries
ARID4AP293747

AlphaFold-only cohort genes (top 30 by pLDDT)

SymbolUniProtpLDDT
KIAA0586Q9BVV647.61

Function

Pathway analysis

Distinct Reactome pathways touched by cohort: 8. Enrichment computed across 2 evidence-associated genes (1 with Reactome annotation).

Pathways by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 1 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

PathwayCohort genesFoldFDRSample cohort genes
HDACs deacetylate histones1120.2×0.028ARID4A
Potential therapeutics for SARS1114.2×0.028ARID4A
Chromatin organization181.6×0.028ARID4A
Chromatin modifying enzymes172.3×0.028ARID4A
SARS-CoV Infections155.4×0.029ARID4A
Viral Infection Pathways130.8×0.043ARID4A
Infectious disease124.8×0.046ARID4A
Disease113.1×0.076ARID4A

GO biological processes by enrichment

Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 2 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.

GO termCohort genesFoldFDRSample cohort genes
establishment of Sertoli cell barrier11685.2×0.007ARID4A
regulation of establishment of protein localization11203.7×0.007KIAA0586
genomic imprinting1495.6×0.010ARID4A
negative regulation of stem cell population maintenance1383.0×0.010ARID4A
erythrocyte development1263.3×0.012ARID4A
positive regulation of stem cell population maintenance1172.0×0.015ARID4A
smoothened signaling pathway190.6×0.023KIAA0586
negative regulation of transforming growth factor beta receptor signaling pathway186.9×0.023ARID4A
negative regulation of cell migration155.8×0.032ARID4A
cilium assembly136.8×0.041KIAA0586
transcription by RNA polymerase II135.3×0.041ARID4A
spermatogenesis117.6×0.075ARID4A
negative regulation of DNA-templated transcription115.8×0.077ARID4A
negative regulation of transcription by RNA polymerase II18.9×0.125ARID4A
positive regulation of transcription by RNA polymerase II17.4×0.139ARID4A
regulation of transcription by RNA polymerase II15.8×0.164ARID4A

Therapeutics

Drug target analysis

Approved (phase 4): 0 · Phase ≥3: 0 · Phased (≥1): 0 · Undrugged: 2

Druggability breadth: 1 of 2 evidence-associated genes (50%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).

Top cohort targets by molecule count

SymbolMoleculesMax phase
KIAA058600
ARID4A00

Bioactivity and enzyme data

Enzyme cohort genes (≥1 EC): 0.

Cohort genes with ChEMBL bioactivity (full, sorted by assay count)

SymbolAssaysType breakdown
ARID4A5Binding:5

Pharmacogenomics

Cohort genes with a PharmGKB record: 2; with CPIC/DPWG dosing guidelines: 0.

No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).

Chemical tractability of cohort targets

0 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.

Druggability pyramid

Cohort genes binned by druggability tier (high → low):

TierDefinitionGenesSymbols
AApproved (phase 4 drug)0
BPhased (≥1) drug, not yet approved0
CDruggable family + PDB, no drug0
DDruggable family + AlphaFold only, no drug0
EDifficult family or no structure, no drug2KIAA0586, ARID4A

Undrugged target profiles

2 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).

SymbolChEMBL assaysDrugged partners (top 3)
KIAA05860
ARID4A5

Clinical trials & evidence

Clinical trials

Clinical trials: 0.